Tandem Diabetes Care reports Q2 2024 results via press release (exhibit text not provided)

TANDEM DIABETES CARE INC

2024-Q2 EPS reported -$1.13 revenue$413,584,000

Filed 8-K indicating a press release was issued on Aug 1, 2024 for Q2 ended June 30, 2024.
Exhibit 99.1 containing the press release was not provided in the input; specific financial figures unavailable.
Investors should refer to the actual press release for detailed results.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.